Twist Bioscience Corporat...

NASDAQ: TWST · Real-Time Price · USD
28.65
-0.19 (-0.66%)
At close: Aug 15, 2025, 12:49 PM

Twist Bioscience Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
312.97M 245.11M 203.56M 132.33M
Cost of Revenue
179.63M 155.38M 119.33M 80.62M
Gross Profit
133.35M 89.73M 84.23M 51.71M
Operating Income
-220.83M -217.16M -249.02M -153.26M
Interest Income
15.34M 14.37M 3.06M 435K
Pretax Income
-208.17M -203.47M -228.27M -154.03M
Net Income
-208.73M -204.62M -217.86M -152.1M
Selling & General & Admin
218.4M 189.74M 212.95M 135.9M
Research & Development
90.85M 106.89M 120.31M 69.07M
Other Expenses
44.93M 10.26M -1.09M -1.37M
Operating Expenses
354.18M 306.89M 333.26M 204.97M
Interest Expense
29K 5K 80K 367K
Selling & Marketing Expenses
n/a 2.9M 2.4M 2.5M
Cost & Expenses
533.8M 462.27M 452.59M 285.59M
Income Tax Expense
560K 1.15M -10.41M -1.93M
Shares Outstanding (Basic)
58.02M 56.88M 53.88M 48.25M
Shares Outstanding (Diluted)
58.02M 56.88M 53.88M 48.25M
EPS (Basic)
-3.6 -3.6 -4.04 -3.15
EPS (Diluted)
-3.6 -3.6 -4.04 -3.15
EBITDA
-176.71M -174.15M -191.55M -143.91M
EBIT
-208.14M -203.46M -228.19M -153.66M
Depreciation & Amortization
31.43M 29.31M 36.64M 11.99M